These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
561 related items for PubMed ID: 1234728
1. Pharmacopoeia as quality codex for the manufacturers. Soldi A. Ann Ist Super Sanita; 1975; 11(3-4):269-80. PubMed ID: 1234728 [Abstract] [Full Text] [Related]
2. Role and functions of the International Pharmacopoeia. Wieniawski W. Ann Ist Super Sanita; 1975; 11(3-4):204-10. PubMed ID: 1234722 [Abstract] [Full Text] [Related]
4. Pharmacopoeia as a pharmaceutical code for public health authorities. Marini-Bettolo GB. Ann Ist Super Sanita; 1975; 11(3-4):254-68. PubMed ID: 1234727 [Abstract] [Full Text] [Related]
5. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report. World Health Organization. World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973 [Abstract] [Full Text] [Related]
6. WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445 [Abstract] [Full Text] [Related]
7. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach. Vergote V, Burvenich C, Van de Wiele C, De Spiegeleer B. J Pept Sci; 2009 Nov; 15(11):697-710. PubMed ID: 19750489 [Abstract] [Full Text] [Related]
8. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 1999 Nov; 885():i-vi, 1-156. PubMed ID: 10352573 [Abstract] [Full Text] [Related]
9. The role of the pharmacopoeia in the control of pharmaceutical preparations. Grainger HS. Ann Ist Super Sanita; 1975 Nov; 11(3-4):305-13. PubMed ID: 1234732 [Abstract] [Full Text] [Related]
10. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 2003 Nov; 917():i-viii, 1-125, back cover. PubMed ID: 15024913 [Abstract] [Full Text] [Related]
11. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization. World Health Organ Tech Rep Ser; 2014 Nov; (986):1-387, back cover. PubMed ID: 24964711 [Abstract] [Full Text] [Related]
12. [The GDR pharmacopoeia--present situation and outlook with special consideration of quality control]. Wagler M. Pharmazie; 1989 Jun; 44(6):386-9. PubMed ID: 2672045 [Abstract] [Full Text] [Related]
13. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE, Kleijnen J. Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [Abstract] [Full Text] [Related]
14. [Animal experiments in the context of quality control of pharmaceuticals. Review of the European Pharmacopoeia, 4th edition, 2002]. Sponer G. ALTEX; 2004 Nov; 21(2):73-80. PubMed ID: 15195228 [Abstract] [Full Text] [Related]
15. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization. World Health Organ Tech Rep Ser; 2012 Nov; (970):1-235, back cover. PubMed ID: 22894011 [Abstract] [Full Text] [Related]
16. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE, Kleijnen J. Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [Abstract] [Full Text] [Related]
17. Design and international harmonization of pharmacopoeial standards. Calam DH. J Pharm Biomed Anal; 1995 Dec; 14(1-2):1-5. PubMed ID: 8833960 [Abstract] [Full Text] [Related]
18. Three Rs potential in the development and quality control of immunobiologicals. Halder M. ALTEX; 2001 Dec; 18 Suppl 1():13-47. PubMed ID: 11854853 [Abstract] [Full Text] [Related]
19. [An analysis of the pharmaceuticals market in Vietnam]. Simonet D. Sante; 2001 Dec; 11(3):155-60. PubMed ID: 11641078 [Abstract] [Full Text] [Related]
20. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives. Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428 [Abstract] [Full Text] [Related] Page: [Next] [New Search]